Dr. Watowich is inventor of Ridgeline Therapeutics’ technology, upon which he founded the company. He serves as the company’s interim CEO to help with the launch and capitalization of the company.Additionally, he is Associate Professor of Biochemistry & Molecular Biology at the University of Texas Medical Branch and recent director of the University of Texas (UT) System’s state-wide entrepreneurship program developed in partnership with UT McCombs School of Business. He is an accomplished educator, researcher, serial inventor, entrepreneur, and developer of innovative world-class resources.
